Literature DB >> 23071343

Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis.

John W Warren1, Daniel J Clauw.   

Abstract

OBJECTIVE: Functional somatic syndromes have no laboratory or pathologic abnormalities and so are diagnosed by symptom-based case definitions. However, many studies, including recent ones, have used self-reports of physician diagnosis rather than the case definitions. Our objective was to determine the sensitivities and specificities of self-report of physician diagnosis for chronic fatigue syndrome (CFS), fibromyalgia (FM), irritable bowel syndrome (IBS), panic disorder, and migraine.
METHODS: Each of 312 female patients with incident interstitial cystitis/bladder pain syndrome and matched population-based controls were queried on self-report of physician diagnosis and separately on established case definitions for each of these syndromes.
RESULTS: Using the symptom-based case definitions as standards, we found that self-report of physician diagnosis did not identify 90% of the controls who had CFS, 77% who had FM, 69% who had IBS, 43% who had panic disorder, and 23% who had migraine. In addition, it missed most individuals with multiple syndromes. Findings in one cohort (controls) were confirmed in another (patients with interstitial cystitis/bladder pain syndrome).
CONCLUSIONS: Self-report of physician diagnosis did not identify most of the three most venerable functional somatic syndromes, IBS, FM, and, especially, CFS; nor did it identify substantial minorities of individuals with panic disorder and migraine. Self-report of physician diagnosis was particularly poor in recognizing persons with multiple syndromes. The insensitivity of this diagnostic test has effects on not only prevalence and incidence estimates but also correlates, comorbidities, and case recruitment. To reveal individuals with these syndromes, singly or together, queries of symptoms, not diagnoses, are necessary.

Entities:  

Mesh:

Year:  2012        PMID: 23071343     DOI: 10.1097/PSY.0b013e31827264aa

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  10 in total

Review 1.  Fibromyalgia comorbid with anxiety disorders and depression: combined medical and psychological treatment.

Authors:  Marcio Bernik; Thiago P A Sampaio; Lucas Gandarela
Journal:  Curr Pain Headache Rep       Date:  2013-09

2.  Classifying Fibromyalgia Syndrome as a Mental Disorder?-An Ambulatory Assessment Study.

Authors:  Kristina Klaus; Susanne Fischer; Johanna M Doerr; Urs M Nater; Ricarda Mewes
Journal:  Int J Behav Med       Date:  2017-04

3.  Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.

Authors:  Kevin F Boehnke; Joel J Gagnier; Lynne Matallana; David A Williams
Journal:  J Pain       Date:  2021-05-13       Impact factor: 5.820

4.  Diagnostic barriers for somatic symptom disorders in primary care: study protocol for a mixed methods study in Germany.

Authors:  Christina Heinbokel; Marco Lehmann; Nadine Janis Pohontsch; Thomas Zimmermann; Astrid Althaus; Martin Scherer; Bernd Löwe
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

5.  Somatoform disorder as a predictor of interstitial cystitis/bladder pain syndrome: Evidence from a nested case-control study and a retrospective cohort study.

Authors:  I-Chun Chen; Ming-Huei Lee; Hsuan-Hung Lin; Shang-Liang Wu; Kun-Min Chang; Hsiu-Ying Lin
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

6.  The Problematic Nature of Fibromyalgia Diagnosis in the Community.

Authors:  Sachin Srinivasan; Eamon Maloney; Brynn Wright; Michael Kennedy; K James Kallail; Johannes J Rasker; Winfried Häuser; Frederick Wolfe
Journal:  ACR Open Rheumatol       Date:  2019-03-15

Review 7.  The Evolution of Fibromyalgia, Its Concepts, and Criteria.

Authors:  Frederick Wolfe; Johannes J Rasker
Journal:  Cureus       Date:  2021-11-29

8.  Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.

Authors:  Kevin F Boehnke; Joel J Gagnier; Lynne Matallana; David A Williams
Journal:  J Pain       Date:  2021-06-30       Impact factor: 5.820

9.  Functional somatic syndromes: asking about exclusionary medical conditions results in decreased prevalence and overlap rates.

Authors:  Susanne Fischer; Urs M Nater
Journal:  BMC Public Health       Date:  2014-10-04       Impact factor: 3.295

10.  Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study.

Authors:  Rei Monden; Judith G M Rosmalen; Klaas J Wardenaar; Francis Creed
Journal:  Psychol Med       Date:  2020-06-17       Impact factor: 7.723

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.